Target type: biologicalprocess
The process in which a T cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex. [GOC:add, PMID:11417857, PMID:15120183]
T cell antigen processing and presentation is a critical step in the adaptive immune response, enabling the recognition and destruction of pathogens and infected cells. This process involves the following steps:
1. **Antigen Uptake:**
- Antigen-presenting cells (APCs), such as dendritic cells, macrophages, and B cells, engulf pathogens or cellular debris through phagocytosis, macropinocytosis, or receptor-mediated endocytosis.
2. **Antigen Processing:**
- Within the APC, the internalized antigen is processed into smaller peptide fragments. This processing occurs in two main pathways:
- **MHC class I pathway:** Processes intracellular antigens, such as viral proteins, and presents them to cytotoxic CD8+ T cells.
- **MHC class II pathway:** Processes extracellular antigens, such as bacterial proteins, and presents them to helper CD4+ T cells.
3. **MHC Class I Pathway:**
- **Proteasome Degradation:** The antigen is degraded by the proteasome, a multi-protein complex, into short peptides of 8-10 amino acids.
- **TAP Transport:** These peptides are transported from the cytoplasm into the endoplasmic reticulum (ER) by the transporter associated with antigen processing (TAP).
- **Loading onto MHC I:** In the ER, peptides bind to MHC class I molecules, which are also assembled in the ER. The MHC I molecule-peptide complex is then transported to the cell surface.
4. **MHC Class II Pathway:**
- **Endocytosis:** The antigen is taken up into endosomes.
- **Endosome Maturation:** Endosomes mature into lysosomes, where the antigen is degraded by lysosomal enzymes.
- **MHC II Loading:** Invariant chain (Ii) blocks the binding of peptides to MHC class II molecules in the ER. Ii is degraded in the endosome, allowing the processed peptides to bind to MHC class II.
- **MHC II Presentation:** The MHC class II-peptide complex is then transported to the cell surface.
5. **T Cell Recognition:**
- The MHC-peptide complex on the APC surface is recognized by the T cell receptor (TCR) on a specific T cell. The TCR recognizes both the peptide and the MHC molecule.
- **CD4+ T cells** recognize MHC class II-peptide complexes, while **CD8+ T cells** recognize MHC class I-peptide complexes.
6. **T Cell Activation:**
- Recognition of the MHC-peptide complex activates the T cell, leading to the release of cytokines, proliferation, and differentiation into effector T cells.
- **CD4+ T cells** differentiate into helper T cells, which provide signals to other immune cells, such as B cells.
- **CD8+ T cells** differentiate into cytotoxic T cells, which kill infected or cancerous cells.
7. **Immune Response:**
- The activation of T cells results in the elimination of the pathogen or infected cell, and the establishment of immunological memory for future encounters with the same antigen.'"
Protein | Definition | Taxonomy |
---|---|---|
Lysine-specific demethylase 5D | A lysine-specific demethylase 5D that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9BY66] | Homo sapiens (human) |
Intercellular adhesion molecule 1 | An intercellular adhesion molecule 1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P05362] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
indole | indole; polycyclic heteroarene | Escherichia coli metabolite | |
1,4-benzodioxan | 1,4-benzodioxan: structure in first source | ||
2,4-pyridinedicarboxylic acid | lutidinic acid : A pyridinedicarboxylic acid carrying carboxy groups at positions 2 and 4. | pyridinedicarboxylic acid | |
1-methylindole | 1-methylindole: SKATOLE refers to 3-methylindole; RN given refers to parent cpd; structure methylindole : Any member of the class of indoles carrying one or more methyl substituents. | ||
lovastatin | lovastatin : A fatty acid ester that is mevastatin carrying an additional methyl group on the carbobicyclic skeleton. It is used in as an anticholesteremic drug and has been found in fungal species such as Aspergillus terreus and Pleurotus ostreatus (oyster mushroom). Lovastatin: A fungal metabolite isolated from cultures of Aspergillus terreus. The compound is a potent anticholesteremic agent. It inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It also stimulates the production of low-density lipoprotein receptors in the liver. | delta-lactone; fatty acid ester; hexahydronaphthalenes; polyketide; statin (naturally occurring) | anticholesteremic drug; antineoplastic agent; Aspergillus metabolite; prodrug |
chlorfenethazine | chlorfenethazine: RN given refers to parent cpd; synonym elroquil refers to HCl; structure | phenothiazines | |
2-bromohippuric acid | |||
benzotript | benzotript: anti-gastrinic; active group is amide; structure | ||
oxalylglycine | N-oxalylglycine : An amino dicarboxylic acid that is iminodiacetic acid with an oxo substituent. It is used as an inhibitor of alpha-ketoglutarate dependent (EC 1.14.11.*) enzymes. oxalylglycine: structure given in first source | amino dicarboxylic acid; N-acylglycine | EC 1.14.11.* (oxidoreductase acting on paired donors, 2-oxoglutarate as one donor, incorporating 1 atom each of oxygen into both donors) inhibitor |
pd 144795 | |||
birt 377 | |||
4-[(4-methylphenyl)thio]-2-thieno[2,3-c]pyridinecarboxamide | aryl sulfide | ||
a 286982 | A 286982: inhibits the interaction between leukocyte function-associated antigen-1 and intracellular adhesion molecule-1; structure in first source | ||
bio 1211 | BIO 1211: integrin alpha4beta1 inhibitor; structure in first source | ||
sar 1118 | lifitegrast : An N-acyl-L-alpha-amino acid obtained by formal condensation of the carboxy group of N-[2-(1-benzofuran-6-carbonyl)]-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid with the amino group of 3-(methanesulfonyl)-L-phenylalanine. Used for treatment of keratoconjunctivitis sicca (dry eye syndrome). lifitegrast: An LFA-1 (LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1) antagonist that is used in the treatment of DRY EYE SYNDROMES. | 1-benzofurans; isoquinolines; L-phenylalanine derivative; N-acyl-L-alpha-amino acid; sulfone | anti-inflammatory drug; lymphocyte function-associated antigen-1 antagonist |
3-[[2-(2-pyridinyl)-6-(1,2,4,5-tetrahydro-3-benzazepin-3-yl)-4-pyrimidinyl]amino]propanoic acid | organonitrogen heterocyclic compound |